Investor List:

Top Drug Delivery Series A Investors (9)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Nathan Stebbins, Principal at Flagship Pioneering
Nathan Stebbins
Sweet spot: $7.0M
Range: $500K - $15.0M
Investors in Cambridge (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Drug Delivery
to see your intro paths to Nathan
Photo of Omri Amirav Drory, General Partner at NFX
Omri Amirav Drory
NFX·General Partner
Sweet spot: $3.0M
Range: $500K - $5.0M
Investors in SF Bay Area (CA)
Investors in BioTech, Investors in BioTech, Investors in Drug Delivery, Investors in Drug Delivery, Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Omri
Photo of Hok Hei Tam, Senior Associate at Flagship Pioneering
Hok Hei Tam
Flagship Pioneering·Senior Associate
Sweet spot: $7.0M
Range: $500K - $15.0M
Investors in Cambridge (MA)
Investors in AI, Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Chemicals, Investors in Data Services, Investors in Drug Delivery
to see your intro paths to Hok Hei
Photo of Sabrina Yang, Senior Associate at Flagship Pioneering
Sabrina Yang
Flagship Pioneering·Senior Associate
Sweet spot: $7.0M
Range: $500K - $15.0M
Investors in Cambridge (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Drug Delivery
to see your intro paths to Sabrina
Photo of Roy Oron, Managing Partner at ITI Venture Capital Partners
Roy Oron
Sweet spot: $5.0M
Range: $250K - $10.0M
Investors in AI, Investors in BioTech, Investors in Consumer Internet, Investors in Digital Health, Investors in Drug Delivery, Investors in Future of Work, Investors in Gaming/eSports, Investors in Impact, Investors in Israel (Other Lists), Investors in SaaS, Investors in Semiconductors
to see your intro paths to Roy
Photo of Gladys Nunez, Managing Director at Amgen Ventures
Gladys Nunez
Amgen Ventures·Managing Director
Sweet spot: $6.0M
Range: $2.0M - $10.0M
Investors in Cambridge (MA)
Investors in Boston / New England (Other Lists), Investors in Drug Delivery, Investors in Pharmaceuticals
to see your intro paths to Gladys
Photo of J Seth Strattan PhD, Partner at Two Bear Capital
J Seth Strattan PhD
Sweet spot: $10.0M
Range: $1M - $20.0M
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in Cloud Infrastructure, Investors in Cloud Infrastructure, Investors in Cybersecurity, Investors in Cybersecurity, Investors in Developer Tools, Investors in Developer Tools, Investors in Drug Delivery, Investors in Drug Delivery, Investors in Health IT, Investors in Health IT, Investors in Material Science, Investors in Material Science, Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Investors who invested in female founders (Other Lists)
to see your intro paths to J Seth
Photo of Nima Ronaghi, Associate at Breakout Ventures
Nima Ronaghi
Sweet spot: $3.0M
Range: $500K - $5.0M
Investors in San Francisco (CA)
Investors in AgTech, Investors in AgTech, Investors in BioTech, Investors in BioTech, Investors in Chemicals, Investors in Chemicals, Investors in ClimateTech/CleanTech, Investors in ClimateTech/CleanTech, Investors in DeepTech, Investors in DeepTech, Investors in Drug Delivery, Investors in Drug Delivery, Investors in EnergyTech, Investors in EnergyTech, Investors in Impact, Investors in Impact, Investors in San Francisco Bay Area (Other Lists), Investors in Therapeutics, Investors in Therapeutics
to see your intro paths to Nima
Get new data & insights delivered to your inbox
Firms investing in this space